| Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression P Pellegrini, AM Berghella, TD Beato, S Cicia, D Adorno, CU Casciani Cancer immunology, immunotherapy 42, 1-8, 1996 | 261 | 1996 |
| A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis A Vecchione, B Belletti, F Lovat, S Volinia, G Chiappetta, S Giglio, ... Proceedings of the National Academy of Sciences 110 (24), 9845-9850, 2013 | 208 | 2013 |
| CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response P Pellegrini, AM Berghella, I Contasta, D Adorno Transplant immunology 12 (1), 49-61, 2003 | 123 | 2003 |
| The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune … AM Berghella, P Pellegrini, T Del Beato, M Marini, E Tomei, D Adorno, ... Cancer Immunology, Immunotherapy 45, 241-249, 1997 | 67 | 1997 |
| Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations AM Berghella, P Pellegrini, D Piancatelli, D Maccarone, T Del Beato, ... Cancer Immunology, Immunotherapy 38 (3), 160-166, 1994 | 60 | 1994 |
| Gender-specific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer P Pellegrini, I Contasta, T Del Beato, F Ciccone, AM Berghella Journal of Immunology Research 2011, 2011 | 49 | 2011 |
| Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive … P Pellegrini, I Contasta, AM Berghella, E Gargano, C Mammarella, ... Cancer Immunology, Immunotherapy 49, 388-394, 2000 | 46 | 2000 |
| CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of … P Pellegrini, R Totaro, I Contasta, AM Berghella, A Carolei, D Adorno Neuroimmunomodulation 12 (4), 220-234, 2005 | 40 | 2005 |
| Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions I Contasta, AM Berghella, P Pellegrini, D Adorno Cancer Biotherapy and Radiopharmaceuticals 18 (4), 549-557, 2003 | 40 | 2003 |
| Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer AM Berghella, I Contasta, P Pellegrini, T Del Beato, D Adorno Cancer Biotherapy and Radiopharmaceuticals 17 (1), 43-50, 2002 | 33 | 2002 |
| Ageing gender-specific" Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age AM Berghella, I Contasta, G Marulli, C D’Innocenzo, F Garofalo, F Gizzi, ... Immunity & Ageing 11, 1-16, 2014 | 32 | 2014 |
| IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer AM Berghella, P Pellegrini, TD Beato, D Adorno, CU Casciani Cancer biotherapy & radiopharmaceuticals 12 (4), 265-272, 1997 | 31 | 1997 |
| Bcl-2 and drugs used in the treatment of cancer: new strategies of biotherapy which should not be underestimated AM Berghella, P Pellegrini, I Contasta, T Del Beato, D Adorno Cancer biotherapy & radiopharmaceuticals 13 (4), 225-237, 1998 | 29 | 1998 |
| The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to … AM Berghella, I Contasta, T Del Beato, P Pellegrini Immunity & Ageing 9, 1-12, 2012 | 27 | 2012 |
| A gender-related action of IFNbeta-therapy was found in multiple sclerosis I Contasta, R Totaro, P Pellegrini, T Del Beato, A Carolei, AM Berghella Journal of translational medicine 10, 1-17, 2012 | 26 | 2012 |
| Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules I Contasta, P Pellegrini, AM Berghella, D Adorno Cancer Biotherapy and Radiopharmaceuticals 16 (1), 63-71, 2001 | 24 | 2001 |
| Prognostic significance of immunological evaluation in colorectal cancer AM Berghella, P Pellegrini, T Del Beato, D Maccarone, D Adorno, ... Cancer biotherapy & radiopharmaceuticals 11 (6), 355-361, 1996 | 23 | 1996 |
| The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy AM Berghella, P Pellegrini, T Del Beato, F Ciccone, I Contasta Cancer Immunology, Immunotherapy 60 (10), 1373-1381, 2011 | 22 | 2011 |
| Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? AM Berghella, I Contasta, P Pellegrini, TD Beato, D Adorno Cancer biotherapy & radiopharmaceuticals 21 (5), 468-487, 2006 | 21 | 2006 |
| The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments P Pellegrini, I Contasta, AM Berghella, T Del Beato, CU Casciani, ... Cancer Biotherapy and Radiopharmaceuticals 15 (3), 267-278, 2000 | 20 | 2000 |
